Back to search

Peptide record

TPDB43816

Antiviral standard
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43816
Antiviral
Anti-infective peptides
AI4AVP DRAVP 2.0 Peptipedia
standard
No
A 17-aa standard-residue antiviral peptide sequence curated from AI4AVP, DRAVP 2.0, and Peptipedia, with an available 3D structural model.
Sequence
KQRQNKPPSKPNNDFHF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C92H140N30O26
ACEGILMTWYV
NKP
2082.31
10.83
5
1
2
+3
4.32
-2.376
0.00
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
0
0.00
6
Residue Composition
number
0
A
1
R
3
N
1
D
0
C
0
E
2
Q
0
G
1
H
0
I
0
L
3
K
0
M
2
F
3
P
1
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 1 N: 3 D: 1 C: 0 E: 0 Q: 2 G: 0 H: 1 I: 0 L: 0 K: 3 M: 0 F: 2 P: 3 S: 1 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
17 reviewed residue count
C92H140N30O26 sequence-only estimate (linear, free termini)
2082.31 sequence-only estimate (linear, free termini)
10.83 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
4.32 sequence-only estimate (linear, free termini)
-2.376 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0